Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled clinical trial
Ou, H., Chen, R., Zhou, L., Zhang, Y., Zhao, S., & Yang, Z
[PMID: 26051626] PubMed record related to this compound for laboratory literature review
Compatibility with common autoimmune medications The ACR Convergence 2025 data specifically showed benefit when GLP-1 agonists were added to existing DMARD therapy in RA patients
WARNING This product should not be taken by those with epilepsy or seizure disorders